AI assistant
Sending…
Sanara MedTech Inc. — Director's Dealing 2025
Mar 21, 2025
33339_dirs_2025-03-21_366e0758-9ebd-40a0-b870-628b04e00986.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2025-03-19
Reporting Person: McNeil Michael D. (Ch. Acct. & Ch. Admin. Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-19 | Common Stock | A | 1486 | — | Acquired | 32521 | Direct |
Footnotes
F1: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock vested in full on the date of grant.
More from Sanara MedTech Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Major Shareholding Notification
2026
Apr 14
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 23